Dr Reddy
Dr Reddy's shares tank 5% after Q3 earnings failed to cheer investors
Dr Reddy's Q3 profit up 2% at Rs 1,413 crore; revenue at Rs 8,359 crore
Sanofi looks for accelerated growth in India; plans fast-tracking of product pipeline
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg)
/newsdrum-in/media/media_files/2025/01/24/m2ZtBwcOlcZYN7nh2es6.jpg)
/newsdrum-in/media/media_files/2025/01/24/m2ZtBwcOlcZYN7nh2es6.jpg)
/newsdrum-in/media/media_files/2024/11/05/1AFCNHOpBh6iDBH2PBMF.jpg)
/newsdrum-in/media/media_files/11k1W4kh36Q253Fbapem.jpg)
/newsdrum-in/media/media_files/H0fqSQjGQY0dXjmpfSrb.webp)
/newsdrum-in/media/media_files/3hKlS89AjVriDXvMFe4O.jpg)
/newsdrum-in/media/media_files/8KYIajhwD2evKvYZkZzp.webp)
